Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SPECTRUM PHARMACEUTICALS, INC.

(SPPI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Spectrum Pharmaceuticals, Inc. Announces Appointment of Tom Riga as President and CEO, Effective December 31, 2021

12/01/2021 | 04:00pm EST

Spectrum Pharmaceuticals, Inc. announced that Tom Riga, currently Chief Commercial and Chief Operating Officer, will be the next President and CEO effective December 31, 2021. Spectrum and Joseph Turgeon, President and CEO, have agreed that Mr. Turgeon will retire from Spectrum on December 31, 2021. Mr. Riga joined the company in July 2013 as VP of Corporate Accounts and was named Chief Commercial Officer in August 2014 and Chief Operating Officer in December 2017. Mr. Riga has over 20 years of pharmaceutical leadership experience and has demonstrated a record of success in various positions at Wyeth Ayerst Pharmaceuticals, Eli Lilly and Company, Amgen Inc. and Dendreon Pharmaceuticals LLC.


ę S&P Capital IQ 2021
All news about SPECTRUM PHARMACEUTICALS, INC.
01/20Spectrum Pharmaceuticals to Participate in B. Riley Securities 2022 Virtual Oncology Co..
BU
01/06SPECTRUM PHARMACEUTICALS : Announces New Strategic Investment by Hanmi Pharmaceutical - Fo..
PU
01/06SPECTRUM PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Unregistered Sa..
AQ
01/05Spectrum Pharmaceuticals to Cut 30% of Staff, Prioritize Late-Stage Programs in Restruc..
MT
01/05Spectrum Pharmaceuticals Announces Strategic Restructuring
BU
01/05Spectrum Pharmaceuticals Announces Strategic Restructuring
CI
01/04Spectrum Pharmaceuticals to Get $20 Million Equity Investment from Hanmi Pharmaceutical
MT
01/04Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical
BU
01/04Spectrum Pharmaceuticals, Inc. announced that it expects to receive $20 million in fund..
CI
2021SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) dropped from S&P Biotechnology Select Industr..
CI
More news
Analyst Recommendations on SPECTRUM PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -152 M - -
Net Debt 2021 - - -
P/E ratio 2021 -0,97x
Yield 2021 -
Capitalization 163 M 163 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 4,55x
Nbr of Employees 176
Free-Float -
Chart SPECTRUM PHARMACEUTICALS, INC.
Duration : Period :
Spectrum Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SPECTRUM PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 0,95 $
Average target price 5,75 $
Spread / Average Target 508%
EPS Revisions
Managers and Directors
Thomas J. Riga President, Chief Executive Officer & Director
Kurt A. Gustafson Chief Financial Officer & Executive Vice President
William L. Ashton Chairman
Francois Lebel Chief Medical Officer
Lyndah K. Dreiling Senior Vice President-Clinical Development
Sector and Competitors
1st jan.Capi. (M$)
SPECTRUM PHARMACEUTICALS, INC.-25.51%170
MODERNA, INC.-39.94%61 847
LONZA GROUP AG-20.30%49 060
IQVIA HOLDINGS INC.-16.27%45 129
SEAGEN INC.-19.08%22 875
ICON PUBLIC LIMITED COMPANY-19.15%20 381